Chronic fluoxetine upregulates activity, protein and mRNA levels of cytosolic phospholipase A2 in rat frontal cortex (Q28577930)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

31 January 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Chronic fluoxetine upregulates activity, protein and mRNA levels of cytosolic phospholipase A2 in rat frontal cortex (English)

1 reference

31 January 2017

1 reference

J. S. Rao

1

1 reference

31 January 2017

R. N. Ertley

2

1 reference

31 January 2017

H.-J. Lee

3

1 reference

31 January 2017

S. I. Rapoport

4

1 reference

31 January 2017

R. P. Bazinet

5

1 reference

31 January 2017

publication date

1 November 2006

1 reference

The Pharmacogenomics Journal

31 January 2017

published in

1 reference

31 January 2017

volume

6

1 reference

31 January 2017

issue

6

1 reference

31 January 2017

page(s)

413–420

1 reference

Case history: the discovery of fluoxetine hydrochloride (Prozac)

31 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500391

Chronic citalopram and fluoxetine treatments upregulate 5-HT2c receptors in the rat choroid plexus

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500391

The functions of five distinct mammalian phospholipase A2S in regulating arachidonic acid release. Type IIa and type V secretory phospholipase A2S are functionally redundant and act in concert with cytosolic phospholipase A2

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500391

Prostaglandins and leukotrienes: advances in eicosanoid biology

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500391

Decrease in the AP-2 DNA-binding activity and in the protein expression of AP-2 alpha and AP-2 beta in frontal cortex of rats treated with lithium for 6 weeks

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500391

5'-flanking region surrounding a human cytosolic phospholipase A2 gene

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500391

Identification of the phosphorylation sites of cytosolic phospholipase A2 in agonist-stimulated human platelets and HeLa cells

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500391

Serine 727 phosphorylation and activation of cytosolic phospholipase A2 by MNK1-related protein kinases

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500391

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.TPJ.6500391

Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

Effects of chronic fluoxetine treatment in the presence and absence of (+/-)pindolol: a microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

Chronic fluoxetine differentially affects 5-hydroxytryptamine (2A) receptor signaling in frontal cortex, oxytocin- and corticotropin-releasing factor-containing neurons in rat paraventricular nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

Frontal 5-HT2A receptors studied in depressive patients during chronic treatment by selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

Functional coupling between various phospholipase A2s and cyclooxygenases in immediate and delayed prostanoid biosynthetic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

Group-specific assays that distinguish between the four major types of mammalian phospholipase A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

Cyclo-oxygenase isoenzymes: physiological and pharmacological role

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

Eicosanoids in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

Serotonin stimulates phospholipase A2 and the release of arachidonic acid in hippocampal neurons by a type 2 serotonin receptor that is independent of inositolphospholipid hydrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

Mobilization of arachidonate and docosahexaenoate by stimulation of the 5-HT2A receptor in rat C6 glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

5-HT2A/2C receptor signaling via phospholipase A2 and arachidonic acid is attenuated in mice lacking the serotonin reuptake transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

Rapid desensitization of the serotonin(2C) receptor system: effector pathway and agonist dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

Dopamine-1 receptor G-protein coupling and the involvement of phospholipase A2 in dopamine-1 receptor mediated cellular signaling mechanisms in the proximal tubules of SHR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

Imaging brain phospholipase A2-mediated signal transduction in response to acute fluoxetine administration in unanesthetized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

Chronic carbamazepine decreases the incorporation rate and turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids of the unanesthetized rat: relevance to bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

Lithium decreases turnover of arachidonate in several brain phospholipids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

Chronic carbamazepine selectively downregulates cytosolic phospholipase A2 expression and cyclooxygenase activity in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

85 kDa cytosolic phospholipase A2 is a target for chronic lithium in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

Antidepressants in bipolar disorder: the case for caution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

The involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathway-mediated mRNA stabilisation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

Prefrontal cortical-amygdalar metabolism in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

Depression: what we can learn from postmortem studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

Neuroimaging abnormalities in the subgenual prefrontal cortex: implications for the pathophysiology of familial mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

Effects of repeated fluoxetine on anxiety-related behaviours, central serotonergic systems, and the corticotropic axis axis in SHR and WKY rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

Cytosolic phospholipase A2 gene expression in rat mesangial cells is regulated post-transcriptionally

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

Activation of p38 mitogen-activated protein kinase/cytosolic phospholipase A2 cascade in hydroperoxide-stressed platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

Chronic valproate does not alter the kinetics of docosahexaenoic acid within brain phospholipids of the unanesthetized rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

Dynamics of docosahexaenoic acid metabolism in the central nervous system: lack of effect of chronic lithium treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

Valproic acid selectively inhibits conversion of arachidonic acid to arachidonoyl-CoA by brain microsomal long-chain fatty acyl-CoA synthetases: relevance to bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

The effect of chronic lithium on arachidonic acid release and metabolism in rat brain does not involve secretory phospholipase A2 or lipoxygenase/cytochrome P450 pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

Isolation and characterization of the epsilon subspecies of protein kinase C from rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

Biphasic inhibition of adrenocorticotropin release by corticosterone in cultured anterior pituitary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

Role of arachidonic acid metabolism on corticotropin-releasing factor (CRF)-release induced by interleukin-1 from superfused rat hypothalami

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

Behavioral, neurochemical, and electrophysiological characterization of a genetic mouse model of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

Effects of chronic fluoxetine in animal models of anxiety and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

Distinguishing phospholipase A2 types in biological samples by employing group-specific assays in the presence of inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

5-HT1A autoreceptors and the mode of action of selective serotonin reuptake inhibitors (SSRI)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

7 January 2021

Chronic fluoxetine or desmethylimipramine treatment alters 5-HT2 receptor mediated c-fos gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

7 January 2021

Involvement of group VI Ca2+-independent phospholipase A2 in protein kinase C-dependent arachidonic acid liberation in zymosan-stimulated macrophage-like P388D1 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

7 January 2021

Chronic lithium chloride administration attenuates brain NMDA receptor-initiated signaling via arachidonic acid in unanesthetized rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

7 January 2021

Bilobalide, a constituent of Ginkgo biloba, inhibits NMDA-induced phospholipase A2 activation and phospholipid breakdown in rat hippocampus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

7 January 2021

Influence of dose and route of administration on the kinetics of fluoxetine and its metabolite norfluoxetine in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500391

7 January 2021

Identifiers

DOI

10.1038/SJ.TPJ.6500391

1 reference

Dimensions Publication ID

31 January 2017

1031327244

0 references

1 reference